Coramaze Technologies Information

Coramaze is an early-stage medical device company, focused on developing Tripair™, a novel, minimally invasive tricuspid valve repair technology designed to treat tricuspid regurgitation —a condition that affects millions globally, with the vast majority currently remaining untreated. Tripair™ is designed to simplify tricuspid valve repair through an innovative transcatheter edge-to-spacer approach. By addressing the key challenges of procedural complexity and limited adoption, it aims to expand access to care and improve outcomes for patients in both established and underserved markets. Coramaze is a pre-commercial stage company that has offices in Germany and Israel. Coramaze's Tripair™ technology is an investigational device and is not yet available for commercial use.